TrivarX Limited (ASX:TRI)

Australia flag Australia · Delayed Price · Currency is AUD
0.0230
+0.0010 (4.55%)
Mar 10, 2026, 12:51 PM AEST
35.29%
Market Cap 25.38M
Revenue (ttm) -95.36K
Net Income (ttm) -2.11M
Shares Out 1.15B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 250,000
Average Volume 1,720,919
Open 0.0230
Previous Close 0.0220
Day's Range 0.0230 - 0.0230
52-Week Range 0.0070 - 0.0350
Beta 0.46
RSI 46.85
Earnings Date Feb 27, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia. [Read more]

Sector Healthcare
Founded 1987
Employees 6
Stock Exchange Australian Securities Exchange
Ticker Symbol TRI
Full Company Profile

Financial Performance

In fiscal year 2025, TrivarX's revenue was 1.03 million, an increase of 16.00% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.

Financial Statements

News

There is no news available yet.